Skip to main content

Peer Review reports

From: The Hippo pathway terminal effector TAZ/WWTR1 mediates oxaliplatin sensitivity in p53 proficient colon cancer cells

Original Submission
25 Sep 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
30 Oct 2023 Reviewed Reviewer Report
13 Dec 2023 Reviewed Reviewer Report
28 Feb 2024 Author responded Author comments - Alexandre Djiane
Resubmission - Version 3
28 Feb 2024 Submitted Manuscript version 3
13 Mar 2024 Reviewed Reviewer Report
3 Apr 2024 Reviewed Reviewer Report
4 Apr 2024 Author responded Author comments - Alexandre Djiane
Resubmission - Version 4
4 Apr 2024 Submitted Manuscript version 4
18 Apr 2024 Author responded Author comments - Alexandre Djiane
Resubmission - Version 5
18 Apr 2024 Submitted Manuscript version 5
Publishing
29 Apr 2024 Editorially accepted
14 May 2024 Article published 10.1186/s12885-024-12316-4

You can find further information about peer review here.

Back to article page